Pharmacoeconomic Modeling Disclaimer Proposed By ISPOR Panel
Executive Summary
Pharmacoeconomic studies that employ modeling should be accompanied by an appropriate disclaimer, an International Society for Pharmacoeconomics and Outcomes Research advisory panel recommended Feb. 20 at an ISPOR conference in Crystal City, Va.